177 related articles for article (PubMed ID: 10320142)
1. Subependymomas: clinicopathologic study of 14 tumors, including comparative MIB-1 immunohistochemical analysis with other ependymal neoplasms.
Prayson RA; Suh JH
Arch Pathol Lab Med; 1999 Apr; 123(4):306-9. PubMed ID: 10320142
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.
Prayson RA
Ann Diagn Pathol; 1999 Feb; 3(1):11-8. PubMed ID: 9990108
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic subependymomas of the ventricles. Review of twenty consecutive cases.
Vitanovics D; Áfra D; Nagy G; Hanzely Z; Turányi E; Banczerowski P
Ideggyogy Sz; 2014 Nov; 67(11-12):415-9. PubMed ID: 25720244
[TBL] [Abstract][Full Text] [Related]
4. Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity.
Prayson RA
Mod Pathol; 1997 Apr; 10(4):304-10. PubMed ID: 9110291
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases.
Machen SK; Prayson RA
Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840
[TBL] [Abstract][Full Text] [Related]
6. Supratentorial extraventricular ependymal neoplasms: a clinicopathologic study of 32 patients.
Shuangshoti S; Rushing EJ; Mena H; Olsen C; Sandberg GD
Cancer; 2005 Jun; 103(12):2598-605. PubMed ID: 15861411
[TBL] [Abstract][Full Text] [Related]
7. Subependymomas Are Low-Grade Heterogeneous Glial Neoplasms Defined by Subventricular Zone Lineage Markers.
D'Amico RS; Praver M; Zanazzi GJ; Englander ZK; Sims JS; Samanamud JL; Ogden AT; McCormick PC; Feldstein NA; McKhann GM; Sisti MB; Canoll P; Bruce JN
World Neurosurg; 2017 Nov; 107():451-463. PubMed ID: 28804038
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases.
Prayson RA
Am J Clin Pathol; 1998 Nov; 110(5):629-34. PubMed ID: 9802348
[TBL] [Abstract][Full Text] [Related]
9. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
10. Recurrent subependymoma of fourth ventricle with unusual atypical histological features: A case report.
Tiwari N; Powell SZ; Takei H
Pathol Int; 2015 Aug; 65(8):438-42. PubMed ID: 26059172
[TBL] [Abstract][Full Text] [Related]
11. Subependymomas: a clinicopathological study of 6 symptomatic cases.
Limaïem F; Bellil SB; Bellil K; Chelly I; Jemel H; Haouet S; Khaldi M; Zitouna M; Kchir N
Pathologica; 2008 Oct; 100(5):401-4. PubMed ID: 19253599
[TBL] [Abstract][Full Text] [Related]
12. Expression of telomerase RNA component correlates with the MIB-1 proliferation index in ependymomas.
Rushing EJ; Yashima K; Brown DF; White CL; Shay JW; Risser RC; Gazdar AF
J Neuropathol Exp Neurol; 1997 Oct; 56(10):1142-6. PubMed ID: 9329458
[TBL] [Abstract][Full Text] [Related]
13. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.
Abramovich CM; Prayson RA
Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry.
Schwimer CJ; Prayson RA
Ann Diagn Pathol; 2001 Jun; 5(3):148-54. PubMed ID: 11436168
[TBL] [Abstract][Full Text] [Related]
15. Intracranial subependymomas: CT and MR imaging features in 24 cases.
Chiechi MV; Smirniotopoulos JG; Jones RV
AJR Am J Roentgenol; 1995 Nov; 165(5):1245-50. PubMed ID: 7572512
[TBL] [Abstract][Full Text] [Related]
16. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
17. Subependymoma revisited: clinicopathological evaluation of 83 cases.
Rushing EJ; Cooper PB; Quezado M; Begnami M; Crespo A; Smirniotopoulos JG; Ecklund J; Olsen C; Santi M
J Neurooncol; 2007 Dec; 85(3):297-305. PubMed ID: 17569000
[TBL] [Abstract][Full Text] [Related]
18. Subependymomas - Characteristics of a "Leave me Alone" Lesion.
Kammerer S; Mueller-Eschner M; Lauer A; Luger AL; Quick-Weller J; Franz K; Harter P; Berkefeld J; Wagner M
Rofo; 2018 Oct; 190(10):955-966. PubMed ID: 29913520
[TBL] [Abstract][Full Text] [Related]
19. Subependymomas of the lateral ventricle: tumor recurrence correlated with increased Ki-67 labeling index.
Koutourousiou M; Georgakoulias N; Kontogeorgos G; Seretis A
Neurol India; 2009; 57(2):191-3. PubMed ID: 19439853
[TBL] [Abstract][Full Text] [Related]
20. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
